Company Filing History:
1 out of 832,880 Years Active: 2025
Title: Innovations by Shuji Akai in Drug Delivery Systems
Introduction
Shuji Akai is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of drug delivery systems, focusing on enhancing the efficacy and safety of therapeutic techniques. His innovative approach aims to improve drug accumulation in targeted lesions while minimizing exposure to normal organs.
Latest Patents
Shuji Akai holds a patent for a drug delivery composition, method for producing the same, and its use. The patent describes a safe and effective drug delivery system (DDS) that achieves higher accumulation in lesions and reduced accumulation in normal organs, including the liver. This invention allows for sufficient therapeutic effects with smaller amounts of drugs. The composition features carbonate apatite particles loaded with a drug, with an average particle size greater than 500 nm and not exceeding 1000 nm. The primary particles are formed in the presence of a polyethylene glycol (PEG) derivative, which has one or more carboxylic acids or their derivatives at the ends. The PEG derivative is incorporated into the primary particles, enhancing the drug delivery process.
Career Highlights
Throughout his career, Shuji Akai has focused on developing innovative solutions in the pharmaceutical field. His work has led to advancements in drug delivery techniques, which are crucial for improving patient outcomes. His dedication to research and development has positioned him as a key figure in this area of study.
Collaborations
Shuji Akai has collaborated with notable colleagues, including Hirofumi Yamamoto and Masaki Mori. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work in drug delivery systems.
Conclusion
Shuji Akai's contributions to drug delivery innovations demonstrate his commitment to improving therapeutic techniques. His patent reflects a significant advancement in the field, showcasing the potential for safer and more effective treatment options. The ongoing collaboration with his colleagues further emphasizes the importance of teamwork in driving innovation forward.